BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34699662)

  • 1. Letter to the editor regarding the article ''Patil S, Patil A. Systemic lupus erythematosus after COVID-19 vaccination: A case report. J Cosmet Dermatol. 2021 Aug 21. 10.1111/jocd.14386".
    Abdullah L; Awada B; Kurban M; Abbas O
    J Cosmet Dermatol; 2021 Dec; 20(12):4076-4077. PubMed ID: 34699662
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter to the editor regarding the article ''Rossi A, Magri F, Michelini S, et al. New onset of alopecia areata in a patient with SARS-COV-2 infection: Possible pathogenetic correlations? J Cosmet Dermatol. 2021 Mar 19. doi: 10.1111/jocd.14080".
    Abou-Rahal J; Abdullah L; Kurban M; Abbas O
    J Cosmet Dermatol; 2021 Jun; 20(6):1951-1952. PubMed ID: 33853206
    [No Abstract]   [Full Text] [Related]  

  • 3. Systemic lupus erythematosus after COVID-19 vaccination: A case report.
    Patil S; Patil A
    J Cosmet Dermatol; 2021 Oct; 20(10):3103-3104. PubMed ID: 34418261
    [No Abstract]   [Full Text] [Related]  

  • 4. Letter to the editor regarding the article "Oguz Topal I, Kara Polat A, Zindancı İ, et al. Adherence to systemic therapy in patients with psoriasis during the COVID-19 pandemic: A multicenter study. J Cosmet Dermatol. 2021;10.1111/jocd.14610.".
    Potestio L; Camela E; Tajani A; Fabbrocini G; Megna M
    J Cosmet Dermatol; 2022 Mar; 21(3):880-882. PubMed ID: 35037352
    [No Abstract]   [Full Text] [Related]  

  • 5. New-onset systemic lupus erythematosus beginning as class V lupus nephritis after COVID-19 vaccination.
    Zavala-Miranda MF; González-Ibarra SG; Pérez-Arias AA; Uribe-Uribe NO; Mejia-Vilet JM
    Kidney Int; 2021 Dec; 100(6):1340-1341. PubMed ID: 34560139
    [No Abstract]   [Full Text] [Related]  

  • 6. Letter to the editor regarding article "Hlaca N, Zagar T, Kastelan M, Peternel S, Brajac I, Prpic-Massari L. New-onset lichen planus and lichen planus flare in elderly women after COVID-19 vaccination. J Cosmet Dermatol. 2022;10.1111/jocd.15185".
    Potestio L; Villani A; Fabbrocini G; Martora F
    J Cosmet Dermatol; 2023 Jan; 22(1):39-41. PubMed ID: 36343163
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical features of newly diagnosed systemic lupus erythematosus after SARS-CoV-2 vaccination.
    Moriyama M; Noda K; Ito H; Matsushita T; Kurosaka D
    Mod Rheumatol Case Rep; 2023 Dec; 8(1):63-68. PubMed ID: 37348045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An ocular adverse event in temporal association with COVID-19 vaccination in a patient with systemic lupus erythematosus: a case report.
    Jin W; Tang Y; Wen C
    Hum Vaccin Immunother; 2021 Nov; 17(11):4102-4104. PubMed ID: 34617875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Letter to the editor regarding article "Falotico JM, Gu L, Lipner SR. Not just pimple popping: The utility of hybrid telemedicine models beyond acne management amidst the ongoing COVID-19 pandemic. J Cosmet Dermatol. 2022;10.1111/jocd.15256".
    Potestio L; Villani A; Raia F; Fabbrocini G; Martora F
    J Cosmet Dermatol; 2023 Mar; 22(3):1134-1135. PubMed ID: 36700374
    [No Abstract]   [Full Text] [Related]  

  • 10. Local and systemic reactogenicity of COVID-19 vaccine BNT162b2 in patients with systemic lupus erythematosus and rheumatoid arthritis.
    Bartels LE; Ammitzbøll C; Andersen JB; Vils SR; Mistegaard CE; Johannsen AD; Hermansen MF; Thomsen MK; Erikstrup C; Hauge EM; Troldborg A
    Rheumatol Int; 2021 Nov; 41(11):1925-1931. PubMed ID: 34476603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse events and disease flares after SARS-CoV-2 vaccination in patients with systemic lupus erythematosus.
    Barbhaiya M; Levine JM; Siegel CH; Bykerk VP; Jannat-Khah D; Mandl LA
    Clin Rheumatol; 2022 May; 41(5):1619-1622. PubMed ID: 34716843
    [No Abstract]   [Full Text] [Related]  

  • 12. Transition of cutaneous into systemic lupus erythematosus following adenoviral vector-based SARS-CoV-2 vaccination.
    Kreuter A; Burmann SN; Burkert B; Oellig F; Michalowitz AL
    J Eur Acad Dermatol Venereol; 2021 Nov; 35(11):e733-e735. PubMed ID: 34243220
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasmacytoid dendritic cells and type I interferons in flares of systemic lupus erythematosus triggered by COVID-19.
    Nasser N; Kurban M; Abbas O
    Rheumatol Int; 2021 May; 41(5):1019-1020. PubMed ID: 33666725
    [No Abstract]   [Full Text] [Related]  

  • 14. SARS-CoV-2 vaccination efficacy and B-cell depletion therapy in systemic lupus erythematosus: Description of a case.
    Ceccarelli F; Olivieri G; Natalucci F; Alessandri C; Conti F
    Lupus; 2021 Sep; 30(10):1698-1699. PubMed ID: 34192958
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunogenicity, safety and reactogenicity of a heterogeneous booster following the CoronaVac inactivated SARS-CoV-2 vaccine in patients with SLE: a case series.
    Assawasaksakul T; Sathitratanacheewin S; Vichaiwattana P; Wanlapakorn N; Poovorawan Y; Kittanamongkolchai W
    RMD Open; 2021 Dec; 7(3):. PubMed ID: 34862313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Use of COVID-19 Vaccines in Patients with SLE.
    Tang W; Gartshteyn Y; Ricker E; Inzerillo S; Murray S; Khalili L; Askanase A
    Curr Rheumatol Rep; 2021 Nov; 23(11):79. PubMed ID: 34767100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subacute cutaneous lupus erythematosus flare triggered by COVID-19 vaccine.
    Joseph AK; Chong BF
    Dermatol Ther; 2021 Nov; 34(6):e15114. PubMed ID: 34455671
    [No Abstract]   [Full Text] [Related]  

  • 18. Lupus, vaccinations and COVID-19: What we know now.
    Mason A; Anver H; Lwin M; Holroyd C; Faust SN; Edwards CJ
    Lupus; 2021 Sep; 30(10):1541-1552. PubMed ID: 34134555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subacute cutaneous lupus erythematosus induction after SARS-CoV-2 vaccine in a patient with primary biliary cholangitis.
    Zengarini C; Pileri A; Salamone FP; Piraccini BM; Vitale G; La Placa M
    J Eur Acad Dermatol Venereol; 2022 Mar; 36(3):e179-e180. PubMed ID: 34807495
    [No Abstract]   [Full Text] [Related]  

  • 20. Letter to the editor regarding article "Yalici-Armagan B, Tabak GH, Dogan-Gunaydin S, Gulseren D, Akdogan N, Atakan N. Treatment of psoriasis with biologics in the early COVID-19 pandemic: A study examining patient attitudes toward the treatment and disease course. J Cosmet Dermatol. 2021;00:1-5".
    Potestio L; Camela E; Fabbrocini G; Megna M
    J Cosmet Dermatol; 2021 Dec; 20(12):4073-4075. PubMed ID: 34708906
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.